glp 1 vs phentermine for weight loss with GLP-1 agonists obesity treatment TrimRX | Can You Take

A study published in The New England Journal of Medicine in February 2021 focusing on the use of semaglutide (sold as Ozempic, Wegovy, and Rybelsus) for weight loss showed that people lost an average of 6.9 kg (or about 15.2 pounds) of body weight at the end of 40 weeks

Semaglutide, liraglutide, and dulaglutide have all demonstrated modest systolic blood pressure reductions in clinical studies

Reference: Paggers L, Mesotten D, Stragier H

This examination can help determine risk of EWDRpatients who have pre-existing moderate to severe NPDR are more likely to progress to PDR within one to two years after initiation of GLP-1 agonist treatment

The complete 2015 Standards supplement is available at professional.diabetes.org/standards

Regular TSH and free T4 monitoring helps your doctor adjust your Synthroid dose to maintain therapeutic levels